News

Due to ubiquity, optometrists tend to undertreat patients with dry eye.

Catch up on the top stories in optometry during the week of July 28-August 1.

The latest in drug and technology developments and updates from July 2025.

Additionally, the company is exploring different strategic alternative to advance its suprachoroidal space (SCS) platform and drug development pipeline.

The solution was approved by the US Food and Drug Administration in late May 2025.

The new facility has opened just in time to see its first classes held in the fall semester.

Vizz (LENZ Therapeutics) is the first and only aceclidine-based eye drop for presbyopia and is also the first daily solution to correct vision for up to 10 hours.

In this podcast, Marjan Farid, MD; Beeran Meghpara, MD; and John Hovanesian, MD; review the role of neuromodulation in the pathogenesis of dry eye disease (DED). Additionally, the expert panel discusses a case study of a typical patient presenting with DED and reviews current and newly available treatment options.

The expanded clinical suite at Stanton Optical will include keratography, optical coherence tomography, and personalized therapy options for patients with dry eye.

Paul Levine, OD, FAAO, FIAOMC, details a pediatric case of high myopia in which the patient's prescription had increased from –5.75 DS OU to OD –7.00 DS, OS –6.75 DS within a year.

The first-in-class, twice-daily topical formulation is intended for the treatment of nonproliferative diabetic retinopathy and diabetic macular edema.

A total of $7000 in scholarships was awarded to 3 optometry students as part of the National Optometric Student Association (NOSA) scholarship program.

The study's primary objective was to demonstrate that LUMIFY Preservative Free redness reliever eye drops are noninferior to LUMIFY redness reliever eye drops in reducing ocular redness.

The module can be used in combination with Ziemer’s FEMTO LDV Z8 femtosecond laser platform, an all-in-one laser for refractive, cataract, and therapeutic surgery.

Gyrate atrophy of the choroid and retina is a form of choroidal sclerosis and is a rare, progressive, autosomal recessive, inherited genetic disease that primarily affects the ocular tissue.

The company was presented with the PRMA President’s Award, Platinum Recycling Award, and recognitions in Leadership in Environmental Performance.

What we should be telling our patients about the remission of type 2 diabetes with weight loss.

Catch up on the top stories in optometry during the week of July 21-July 25.

The enhanced clarity in the lens helps reduce glare and enhance visual comfort, according to the company.

The campaign provides tools to patients, researchers, clinicians, industry, and advocates with tools to tell their stories that advocate for vision research.

The tool is designed to help with the application of mono-dose, dry eye eye drop vials more easily and accurately.

The solution missed the primary end point of the trial, which was complete resolution of debris after 6 weeks of twice-daily dosing.

The EyeSouth affiliate network now includes more than 320 doctors providing medical and surgical eye care services at over 235 locations.

Santen introduces low-dose atropine in Germany, marking a significant advancement in myopia management for children amid a global epidemic.

This will be the Flying Eye Hospital’s first visit to Rwanda.

Survey participants cited cost concerns, perceived inevitability, and deprioritization as obstacles to receiving eye care.

New research reveals collagen mimetic peptides may effectively restore ocular tissue stiffness, offering hope for myopia and other eye diseases.